SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2013 / Cilt: 43 - Sayı: 2

Alfacalcidol suppresses α-receptor mediated vasoconstriction via an endothelium dependent mechanism

Akif Hakan KURT
İsmail ÜN
Ali BATUŞ
Kansu BÜYÜKAFŞAR
Pages
238–244
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study we report for the first time that alfacalcidol may prevent phenylephrine-induced vasoconstriction in mice aorta with an endothelium-dependent nitric oxide-mediated mechanism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Vitamin D level could be related to blood pressure and cardiovascular health.
📊
Key Findings & Data:Therefore, the effects of alfacalcidol (1α-hydroxyvitamin D3 ) and calcitriol (1α,25- dihydroxyvitamin D3 ) on contractions induced by phenylephrine (10 8 to 10 5 M) in mice aorta were investigated.
💡
Conclusion & Impact:Conclusion: In this study we report for the first time that alfacalcidol may prevent phenylephrine-induced vasoconstriction in mice aorta with an endothelium-dependent nitric oxide-mediated mechanism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Vitamin D level could be related to blood pressure and cardiovascular health. However, the direct suppressor effect of vitamin D on vascular contraction has not yet been explored. Therefore, the effects of alfacalcidol (1α-hydroxyvitamin D3 ) and calcitriol (1α,25- dihydroxyvitamin D3 ) on contractions induced by phenylephrine (10 8 to 10 5 M) in mice aorta were investigated. Materials and methods: Arterial rings were suspended in isolated organ chambers filled with Krebs bicarbonate solution gassed with 95% O2and 5% CO2maintained at 37 °C. Tissue responses were recorded isometrically with a force transducer and displayed on an acquisition system. Alfacalcidol and calcitriol were applied on phenylephrine-induced active tone. Furthermore, aortic rings were preincubated with alfacalcidol and calcitriol and thereafter contracted with phenylephrine. Incubation studies were conducted by endothelium removal and in the presence of L-nitro-arginine methyl ester (L-NAME). Results: Phenylephrine-induced active tones were significantly suppressed by alfacalcidol (P < 0.05 and P < 0.01) and calcitriol (both 10 5 and 10 6 M). The pEC50 values of alfacalcidol and calcitriol were 7.06 ± 0.91 and 7.13 ± 0.60, respectively. Furthermore, preincubation of aortic rings with alfacalcidol (10 5 M) but not calcitriol (10 5 M) significantly inhibited phenylephrine-induced contractions (10 8 to 10 5 M, P < 0.05 and P < 0.001). The suppressive effect of alfacalcidol incubation disappeared with endothelium removal. Furthermore, alfacalcidol was unable to inhibit phenylephrine-induced contractions in the presence of L-NAME, an inhibitor of nitric oxide biosynthesis. Conclusion: In this study we report for the first time that alfacalcidol may prevent phenylephrine-induced vasoconstriction in mice aorta with an endothelium-dependent nitric oxide-mediated mechanism.

🔖

Cite This Article

KURT, A. H., ÜN, İ., BATUŞ, A., BÜYÜKAFŞAR, K. (2022). Alfacalcidol suppresses α-receptor mediated vasoconstriction via an endothelium dependent mechanism. Turkish Journal of Medical Sciences, Cilt: 43 - Sayı: 2, 238–244. https://ajindex.com/articles/611015

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Garcia VC, Martini LA. Vitamin D and cardiovascular disease. Nutrients 2010; 2: 426–37
  2. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503–11
  3. Lind L, Lithell H, Skarfors E, Wide L, Ljunghall S. Reduction of blood pressure by treatment with alfacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand 1988; 223: 211–7
  4. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M. Multiple actions of steroid hormones – a focus on rapid, nongenomic effects. Pharmacol Rev 2000; 52: 513–56
  5. Güzey M. Cloning and transcriptional activation of the vitamin D receptor (amphibians). Turk J Med Sci 1999; 29: 507–12
  6. Yildiz O, Seyrek M, Gul H, Un I, Yildirim V, Ozal E et al. Testosterone relaxes human internal mammary artery in vitro. J Cardiovasc Pharmacol 2005; 45: 580–5
  7. Yildiz O, Seyrek M, Un I, Gul H, Candemir G, Yildirim V. The relationship between risk factors and testosterone-induced relaxations in human internal mammary artery. J Cardiovasc Pharmacol 2005; 45: 4–7
  8. Wong MS, Delansorne R, Man RY, Vanhoutte PM. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2008; 295: 289–96
  9. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13: 325–49
  10. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002; 13: 621–9
  11. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (tPA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994; 269: 21198–203
  12. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994; 269: 21191–7
  13. Baran DT, Quail JM, Ray R, Leszyk J, Honeyman T. Annexin II is the membrane receptor that mediates the rapid actions of 1α,25-dihydroxyvitamin D3. J Cell Biochem 2000; 78: 34–46
  14. Boland AR, Nemere I. Rapid actions of vitamin D